One Month to Go Until CWCI’s 61st Annual Meeting

OAKLAND, Calif.–(BUSINESS WIRE)–#CWCI–The California Workers’ Compensation Institute (CWCI) has announced additional details on its 61st Annual Meeting, which will be held Thursday, April 3 from 9 a.m. to 3 p.m. at the Sofia Tsakopoulos Center for the Arts (aka, “the Sofia”), 2700 Capitol Avenue in downtown Sacramento. The theme of the CWCI meeting will be … [Read more…]

Sila Realty Trust Completes $35.12 Million Acquisition of Knoxville Inpatient Rehabilitation Facility

TAMPA, Fla.–(BUSINESS WIRE)–Sila Realty Trust, Inc. (NYSE: SILA) (the “Company” or “we”), a net lease real estate investment trust (“REIT”) with a strategic focus on investing in the growing and resilient healthcare sector, today announced the $35.12 million acquisition of an inpatient rehabilitation facility located in Knoxville, Tennessee (the “Knoxville Healthcare Facility”). The Knoxville Healthcare … [Read more…]

Mednition Announces Breakthrough AI Sepsis Model with Highest Achieved Performance

New AI model achieves best-in-class AUC results for ED sepsis diagnosis using Sepsis-3 criteria, demonstrating potential to significantly improve patient outcomes. BURLINGAME, Calif.–(BUSINESS WIRE)–#AI–Mednition today announced the development of a groundbreaking AI sepsis model that has achieved the highest published AUC for the diagnosis of Emergency Department (ED) sepsis using the Sepsis-3 criteria. This breakthrough … [Read more…]

Breast Cancer Canada Responds to Minister of Health’s Decision to Pause Canadian Task Force on Preventive Health Care

A Defining Moment to Improve Breast Cancer Screening TORONTO–(BUSINESS WIRE)–Breast Cancer Canada welcomes today’s announcement made by the Honourable Mark Holland, Minister of Health, to temporarily pause the work of the Canadian Task Force on Preventive Health Care. This decision marks a critical opportunity to ensure that further recommendations, including breast cancer screening guidelines, are … [Read more…]

Hemodialysis & Peritoneal Dialysis Research 2025: Market to Reach $168.92 Billion in 2030 from $104 Billion in 2023, Driven by Escalating Demand for Effective Renal Therapies, & Rising CKD and ESRD – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hemodialysis & Peritoneal Dialysis Market (2025 Edition): Analysis By Product (Machines, Dialyzers, Dialysis Solutions, and Catheters & Accessories), By End-User, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)” report has been added to ResearchAndMarkets.com’s offering. The Global Hemodialysis & Peritoneal Dialysis market showcased growth at a CAGR of 6.66% during … [Read more…]

AHF’s Bold Billboard Campaign Stresses Syphilis is Curable

U.S. reported more than 209,000 cases of syphilis at all stages, including congenital syphilis, in 2023 – highest number since 1950 LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) is using an imposing image of a bottle of penicillin and a syringe and needle paired with the words “Syphilis is Curable” and the URL freeSTDcheck.org to draw … [Read more…]

Endometrial immune Profiling and Precision Care Lead to Significantly Higher Live Birth Rates, MatriceLab Trial Shows

PARIS–(BUSINESS WIRE)–MatriceLab Innove announced that the first large-scale randomized controlled trial investigating endometrial immune profiling showed that personalized treatment based on immune testing can significantly increase live birth rates from IVF. The trial showed that patients receiving personalized care based on MatriceLab’s UTIMPRO endometrial immune profiling test had a live birth rate (LBR) of 41.4%, … [Read more…]

Laekna Announces IND Approval of LAE120 (a Novel USP1 Inhibitor) for Treatment of Advanced Solid Tumors by FDA

A novel, allosteric and highly potent USP1 inhibitor, LAE120 exhibits robust tumor inhibitory activity across various xenograft models Significantly accelerated the progress of drug discovery leveraging cutting-edge AI models Another potential anti-tumor drug candidate, LAE118 (a mutant-selective PI3Kα inhibitor) also in IND-enabling studies LOS ANGELES–(BUSINESS WIRE)–#Biotech–Laekna (2105.HK) announced that the U.S. Food and Drug Administration … [Read more…]

Ketone Labs & Blue Pacific Flavors Announce Strategic Partnership to Drive Innovation in goBHB Powered Functional Beverages at Expo West 2025

Anaheim CA – March 4-7, 2025 CITY OF INDUSTRY, Calif.–(BUSINESS WIRE)–Ketone Labs, a leader in beta-hydroxybutyrate (BHB) innovation, has partnered with Blue Pacific Flavors, a premier expert in natural flavor solutions, to pioneer goBHB-powered functional beverages & nutritional products. These groundbreaking non-stimulant energy beverages featuring goBHB, offer clean, sustained energy without caffeine or taurine. The … [Read more…]

Talkdesk AI Agents for Healthcare transforms patient and member experience with agentic artificial intelligence

Talkdesk unlocks the transformative value for providers and payers by applying the next generation of automation to patient and member access, service, and support workflows PALO ALTO, Calif. & LAS VEGAS–(BUSINESS WIRE)–#AIAgents—Talkdesk®, Inc., a global provider of artificial intelligence (AI)-powered customer experience (CX) technology that serves enterprises of all sizes, is helping healthcare organizations effortlessly … [Read more…]